PRospective Multiple Myeloma Impact Study (PROMMIS)


We are doing this study to learn if the MMprofiler test can help your doctor in making decisions about your treatment. The MMprofiler genomic test will look at a large number of normal genes. The test will predict risk of your multiple myeloma by assessing whether these genes are turned on or off in your cancer cells. The purpose of this research is to study whether this test can help your doctor to determine what treatment will be best for your multiple myeloma.

SparkCures ID 920
Enrollment 250 Patients
Trial Sponsors
  • SkylineDx
NCT Identifier


Am I Eligible?

The following criteria is a partial list of reasons why patients may or may not be eligible to participate in this clinical trial. Further evaluation with a medical professional will be required to determine full eligibility.

  • Are at least 18 years.
  • Have multiple myeloma according to IMWG criteria.
  • Are a candidate for systemic treatment.
  • Additional inclusion/exclusion criteria may apply.

The following criteria is provided for health care professionals.

  • Patient is at least 18 years old
  • Patients with Multiple Myeloma according to IMWG criteria or patients highly suspected of having Multiple Myeloma
  • No more than 8 weeks of first line therapy for Multiple Myeloma


There are no resources, links or videos to display for this clinical trial.

Interested in this trial?
  • Call us today 😀 keyboard_arrow_right

    We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.

    (888) 828-2206
  • If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.

  • Talk to your doctor keyboard_arrow_right

    You can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.

Still need help? Send us a message